|
Diabetes Medication Article
What storage conditions are needed for this medicine?Return to top
Store insulin in the refrigerator. Never allow insulin to freeze; do not use insulin that has been frozen and thawed. Never heat insulin to warm it.
If no refrigerator is available (e.g., when on vacation), store the bottle at room temperature and away from direct sunlight and extreme heat. Discard any insulin that has been exposed to extreme heat or cold. When traveling, protect your insulin bottles from bumps or other rough handling (wrap them in clothes in the middle of a suitcase). Do not keep insulin in hot areas of a car such as the glove compartment and trunk.
When traveling by airplane, do not put insulin in checked luggage since the luggage may be lost. Always keep insulin with you or in carry-on luggage. Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
Diabetes Testing Center
Heart News Center
Hot Home Gym Reviews
The Secret Wisdom You Have Inside
Get Rid of Your Belly fat
New Diabetes Drug News
New Diabetes Drug
IMPORTANT: Bing News RSS feed has moved!
Alogliptin belongs to a relatively new class of diabetes drugs called DDP-4 inhibitors for the treatment of type 2 diabetes. It was approved in Japan last year and is marketed under the name Nesina. Dipeptidyl peptidase-4 inhibitors work to ...
Read moreU.S. delays decision on Takeda diabetes drug
GlobalData, the industry analysis specialist, has released its new report, "Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020". The report is an essential source of information and analysis on the global type 2 diabetes therapeutics market.
Read moreType 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020
A “conditional approval’’ approach would grant limited marketing authorization to new drugs after successful Phase II trials ... investing in difficult things like obesity, type 2 diabetes, [and] high blood pressure, which were at risk ...
Read moreHow the FDA Stifles New Cures, Part III: A Proposal for Reform
NEW YORK (AP) -- Shares of diabetes drug maker Amylin Pharmaceuticals Inc. jumped Monday after a report the company is reaching out to potential buyers about a possible sale. THE SPARK: Reuters reported the San Diego company is looking for ...
Read moreAmylin Pharma rises on report of new sale talks
New York, NY (PRWEB) April 24 ... It is planned to be refiled for FDA approval in the second half of 2011 as a once-weekly diabetes drug. GLP-1 analogs such as dulaglutide and albiglutide, along with a modified form of exenatide (lixisenatide), are ...
Read moreMarketsensus: Overcoming Side-Effects Means the Difference Between Profit and Loss for Drug Companies
Glucagon-like peptide 1 mimetics (GLP-1 mimetics) are considered by many endocrinologists to be the most promising new class of diabetes drugs. Amylin Pharmaceuticals and its partner, Eli Lilly, developed the first approved GLP-1 mimetic ...
Read moreHow the FDA Stifles New Cures, Part II: 90% of Clinical Trial Costs are Incurred in Phase III
The study results will be presented at GTC's 5th Diabetes Drug Discovery and Development Conference on ... and we believe it has the potential be a major new treatment for obesity and Type II diabetes that is both effective and safe.
Read morePROLOR Biotech Announces Positive Results of Its Obesity/Diabetes Drug Candidate in Preclinical Weight Loss Study
Some have been from doctors and other health care professionals involved in diabetes care or the treatment of various ... foods to books and websites to elixers and vitamins, new diets and old. I try to look into as many of these as possible ...
Read moreDiary of a Diabetic Chef: Readers weigh in on my diet approach and theirs
depression and anxiety); GLP-1 agonist (Type 2 diabetes); and CXCR-4 antagonists (cancer/HIV). About Heptares Therapeutics Heptares discovers and develops new medicines targeting GPCRs (G-protein-coupled receptors), a super-family of drug targets linked to ...
Read more